QUARK Trademark

Trademark Overview

On Wednesday, June 27, 2018, a trademark application was filed for QUARK with the United States Patent and Trademark Office. The USPTO has given the QUARK trademark a serial number of 88016681. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 6, 2021. This trademark is owned by Quark Pharmaceuticals, Inc.. The QUARK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for treatment of diseases or conditions by regulation of gene expression; pharmaceutical compositions comprising RNA; and pharmaceutical compositions comprising siRNA; all the above for use in the treatment of kidney diseases, eye diseases, lung diseases, cardiac disease, and skin diseases
quark

General Information

Serial Number88016681
Word MarkQUARK
Filing DateWednesday, June 27, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 6, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 9, 2020

Trademark Statements

Description of MarkThe mark consists of the word "QUARK" in blue stylized writing and a grey stylized sinusoidal curve beneath the letters "UARK".
Goods and ServicesPharmaceutical compositions for treatment of diseases or conditions by regulation of gene expression; pharmaceutical compositions comprising RNA; and pharmaceutical compositions comprising siRNA; all the above for use in the treatment of kidney diseases, eye diseases, lung diseases, cardiac disease, and skin diseases
Indication of Colors claimedThe colors blue and grey are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, July 1, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQuark Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, CA 94560
Party NameQuark Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events

Event DateEvent Description
Tuesday, September 7, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 6, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 1, 2021SOU EXTENSION 1 GRANTED
Monday, February 1, 2021SOU EXTENSION 1 FILED
Monday, February 1, 2021TEAS EXTENSION RECEIVED
Tuesday, August 4, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 9, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 9, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 20, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 4, 2020ASSIGNED TO LIE
Monday, April 27, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 23, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 23, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 23, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, December 1, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, December 1, 2019FINAL REFUSAL E-MAILED
Sunday, December 1, 2019FINAL REFUSAL WRITTEN
Wednesday, November 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 12, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 12, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 6, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 6, 2019NON-FINAL ACTION E-MAILED
Monday, May 6, 2019NON-FINAL ACTION WRITTEN
Tuesday, April 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 19, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 19, 2018NON-FINAL ACTION E-MAILED
Friday, October 19, 2018NON-FINAL ACTION WRITTEN
Thursday, October 18, 2018ASSIGNED TO EXAMINER
Tuesday, July 3, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, July 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 30, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

quark diseases pharmaceutical compositions comprising treatment lung skin kidney disease cardiac